Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)

China · Delayed Price · Currency is CNY

29.74

+1.37 (4.83%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medicine Manufacturing	704.16M	588.86M	496.12M	547.48M	487.15M
Medicine Manufacturing Growth	19.58%	18.69%	-9.38%	12.38%	52.18%
Total	704.16M	588.86M	496.12M	547.48M	487.15M
Total Growth	19.58%	18.69%	-9.38%	12.38%	52.18%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	704.16M	588.86M	496.12M	547.48M	487.15M
China Growth	19.58%	18.69%	-9.38%	12.38%	52.18%
Total	704.16M	588.86M	496.12M	547.48M	487.15M
Total Growth	19.58%	18.69%	-9.38%	12.38%	52.18%

Source: S&P Global Market Intelligence.